SCHEMBL3974765

SCHEMBL3974765

N#Cc1c(O)ccc(C(=O)OC(=O)c2occc2-c2ccccc2)c1C(=O)NN

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.36
GAA P10253 4/20 0.36
HPGD P15428 3/20 0.33
XDH P47989 1/20 0.32
SLC22A12 Q96S37 1/20 0.32
PIM1 P11309 3/20 0.32
KISS1R Q969F8 3/20 0.32
MMP1 P03956 1/20 0.31
MMP3 P08254 1/20 0.31
MMP7 P09237 1/20 0.31
MMP9 P14780 1/20 0.31
MMP8 P22894 1/20 0.31
MMP12 P39900 1/20 0.31
MMP13 P45452 1/20 0.31
MEN1 O00255 3/20 0.31
MAPT P10636 3/20 0.31
KMT2A Q03164 3/20 0.31
USP2 O75604 2/20 0.31
POLB P06746 2/20 0.31
ALOX15 P16050 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3978191 0.96 ALDH1A1 (0.35) ALDH1A1GAAHPGDXDHSLC22A12
SCHEMBL3978276 0.93 GRM2 (0.34) ALDH1A1GAAHPGDMEN1MAPT
SCHEMBL3976979 0.91 IKBKB (0.34) ALDH1A1GAAKISS1R
SCHEMBL3973253 0.90 MEN1 (0.36) ALDH1A1XDHSLC22A12KISS1RMEN1
SCHEMBL3985003 0.90 NPC1 (0.34) ALDH1A1MAPTPOLBKDM4EESR1
SCHEMBL3977150 0.90 KISS1R (0.38) XDHSLC22A12KISS1R
SCHEMBL3979525 0.90 MCL1 (0.40) ALDH1A1HPGDPIM1MEN1MAPT
SCHEMBL3983001 0.88 KISS1R (0.45) KISS1RMEN1MAPTKMT2APOLB
SCHEMBL3975937 0.87 ALDH1A1 (0.36) ALDH1A1GAAHPGDMEN1MAPT
SCHEMBL3977732 0.87 GUSB (0.39) ALDH1A1GAAHPGDMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514452-B2 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD (JP) 2009-04-07 US claimed
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-04 US claimed
EP-1489077-A1 2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP claimed
US-7514452-B2 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD (JP) 2009-04-07 US disclosed
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-04 US disclosed
EP-1489077-A1 2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same GLP1R, GCGR, GPR119 ALDH1A1 1389/4885GAA 1023/4885HPGD 299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.